Literature DB >> 11428185

Onset of accumulation of PrPres in murine ME7 scrapie in relation to pathological and PrP immunohistochemical changes.

M Jeffrey1, S Martin, J Barr, A Chong, J R Fraser.   

Abstract

In a murine scrapie model, three different methods (immunohistochemistry, Western blotting and histoblotting) for determining disease-specific PrP accumulation were compared. The incubation period of ME7 scrapie in the F1 cross of C57 BL and VM/Dk mice is about 230 days. Mice show hippocampal neuronal loss from 160-180 days post-inoculation (dpi), CA1 neuron dendritic spine atrophy at 126 dpi, and axon terminal degeneration and synaptic loss from 84-98 dpi. Infectivity titres of at least 100 are present from 40 dpi. PrP was detected immunohistochemically at 60 dpi in the hippocampus and in the thalamus. Thus, PrP accumulation in the hippocampus precedes even the earliest neurodegenerative changes. Low amounts of PrP immunolabelling were found between 60 dpi and 126 dpi, after which the intensity increased markedly. The histoblot method detected PrPres in one of four mice at 100 dpi. Western blotting of whole brains first identified the PrPres at 80 dpi. Thus, in our hands, the most sensitive method for detecting disease-specific accumulations of PrP was immunohistochemical examination. However, immunohistochemical methods are unable to distinguish the normal and abnormal isoforms of PrP. It is therefore possible that the initial accumulation of PrP takes place as PrPsen and that the translation of PrPsen to PrPres does not take place until the later stages of the disease process. The accumulation of disease-specific PrP lags behind the development of infectivity titres. The relative rates of increase of infectivity titre and PrP accumulation are different, suggesting that these parameters may be measures of different biological events.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11428185     DOI: 10.1053/jcpa.2000.0423

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  17 in total

1.  Prions Strongly Reduce NMDA Receptor S-Nitrosylation Levels at Pre-symptomatic and Terminal Stages of Prion Diseases.

Authors:  Elisa Meneghetti; Lisa Gasperini; Tommaso Virgilio; Fabio Moda; Fabrizio Tagliavini; Federico Benetti; Giuseppe Legname
Journal:  Mol Neurobiol       Date:  2019-02-01       Impact factor: 5.590

2.  Detection of bovine spongiform encephalopathy, ovine scrapie prion-related protein (PrPSc) and normal PrPc by monoclonal antibodies raised to copper-refolded prion protein.

Authors:  Alana M Thackray; Jean-Yves Madec; Edmond Wong; Robert Morgan-Warren; David R Brown; Thierry Baron; Raymond Bujdoso
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

Review 3.  Molecular aspects of disease pathogenesis in the transmissible spongiform encephalopathies.

Authors:  Suzette A Priola; Ina Vorberg
Journal:  Mol Biotechnol       Date:  2006-05       Impact factor: 2.695

4.  Early cytokine elevation, PrPres deposition, and gliosis in mouse scrapie: no effect on disease by deletion of cytokine genes IL-12p40 and IL-12p35.

Authors:  Déborah Tribouillard-Tanvier; Brent Race; James F Striebel; James A Carroll; Katie Phillips; Bruce Chesebro
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

5.  Prion infection of mouse brain reveals multiple new upregulated genes involved in neuroinflammation or signal transduction.

Authors:  James A Carroll; James F Striebel; Brent Race; Katie Phillips; Bruce Chesebro
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

6.  Degenerating synaptic boutons in prion disease: microglia activation without synaptic stripping.

Authors:  Zuzana Sisková; Anton Page; Vincent O'Connor; Victor Hugh Perry
Journal:  Am J Pathol       Date:  2009-09-24       Impact factor: 4.307

7.  Stability of murine scrapie strain 87V after passage in sheep and comparison with the CH1641 ovine strain.

Authors:  Lorenzo González; Francesca Chianini; Nora Hunter; Scott Hamilton; Louise Gibbard; Stuart Martin; Mark P Dagleish; Sílvia Sisó; Samantha L Eaton; Angela Chong; Lynne Algar; Martin Jeffrey
Journal:  J Gen Virol       Date:  2015-12       Impact factor: 3.891

8.  Subclinical prion disease induced by oral inoculation.

Authors:  Alana M Thackray; Michael A Klein; Raymond Bujdoso
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

9.  Bax deletion prevents neuronal loss but not neurological symptoms in a transgenic model of inherited prion disease.

Authors:  Roberto Chiesa; Pedro Piccardo; Sara Dossena; Lisa Nowoslawski; Kevin A Roth; Bernardino Ghetti; David A Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-23       Impact factor: 11.205

10.  Differential protein profiling as a potential multi-marker approach for TSE diagnosis.

Authors:  Janice B Barr; Michael Watson; Mark W Head; James W Ironside; Nathan Harris; Caroline Hogarth; Janet R Fraser; Rona Barron
Journal:  BMC Infect Dis       Date:  2009-11-27       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.